NYSE:BSXMedical Equipment
Electrophysiology Lawsuits and China Push Might Change The Case For Investing In Boston Scientific (BSX)
In early 2026, multiple law firms launched or expanded securities class action lawsuits alleging Boston Scientific misled investors about the performance and sustainability of growth in its U.S. Electrophysiology segment, following weaker-than-expected 2025 results and cautious 2026 guidance.
At the same time, Boston Scientific moved ahead with clinical expansion efforts, planning a new China registry for its ENROUTE neuroprotection system and Carotid WALLSTENT to build real-world evidence...